1Hasdai D, Barak V, Leibovitz E, et al. Serum basic fibroblast growth factor levels in patients with ischemic heart disease.Int J Cardiol, 1997, 59 : 133-138.
2Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coil Cardiol,1985,5:587-592.
3Casscells W, Speir E, Sasse J, et al. Isolation, characterization,and localization of heparin-binding growth factors in the heart.J Clin Invest,1990,85:433-441.
4Fujita M, lkemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina.Circulation, 1996,94:610-613.
5Page E, Upshaw-Earley J, Goings G. Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules.Stretch-dependent effects. Circ Res, 1992, 71: 159-173.
6Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000, 87: 840-844.
7Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci, 2000,57:207-213.
8Hughes SE, Hall PA. Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res, 1993,27 : 1199-1203.
1Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[ J]. N Eng J Med,2004;350( 14): 1387-97.
2Madamachi NR, Vendrov A, Rungs MS,et al. Oxidative stress and vascu- lar disease[ J]. Arterioscler Thromb Vasc Bio1,2005 ;25 (1) :29-38.
3Papaioannou AI, Koutsokera A, Tanou K,et al. The acute effect of smok- ing in healthy and asthmatic smokers [ J]. Eur J Clin Invest, 2010; 40 (2) : 103-9.
